South Korea Aesthetic Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The south korea aesthetic devices market size was valued at USD 530.41 million in 2025 and is estimated to grow from USD 567.75 million in 2026 to reach USD 838.63 million by 2031, at a CAGR of 8.11% during the forecast period (2026-2031). This report is Segmented by Device Type (Energy-Based Devices [Laser-Based, Radiofrequency, IPL & Light-Based, Ultrasound/HIFU] Non-Energy Devices [Dermal Fillers & Injectables, and More]), Application (Skin Rejuvenation & Tightening, and More), End User (Hospitals, and More), Gender (Female, Male), Age Group (18-34 Years, and More). The Market Forecasts are Provided in Terms of Value (USD).

South Korea Aesthetic Devices Market Trends and Insights

High Inbound Medical Tourism & K-Beauty Influence

Foreign patient arrivals reached 1.17 million in 2024, and 56.6% sought dermatologic or plastic surgery treatments, injecting USD 2.3 billion in direct spending into the South Korea aesthetic devices market. Chinese and ASEAN visitors, who generate 68% of inbound volume, often request devices they see in K-beauty social media, turning clinics into export-facing showrooms. Manufacturers now co-develop marketing kits with tourism agencies to align clinical evidence with lifestyle branding. The 2025 revision of the Medical Korea visa extends aesthetic stays to 90 days, which should keep the South Korea aesthetic devices market on a double-digit visitor growth path. Still, 22% of foreign patients faced complications from unlicensed providers, highlighting accreditation gaps that could dampen future referrals.

Rapid Adoption of Minimally Invasive & Energy-Based Technologies

Energy-based modalities such as picosecond lasers and monopolar radiofrequency shorten recovery to 48 hours, displacing surgical lifts in urban clinics. Lutronic’s PicoPlus and Cynosure’s PicoSure dominated 2024 installations, underscoring clinician preference for pigment-selective platforms. MFDS fast-track review, introduced in 2025, now clears proven hybrid devices in 12 months, six months faster than before. Hironic’s Infini RF, which couples controlled depth with microneedling, shows how smaller firms exploit the pathway to win niche indications. These shifts funnel steady replacement demand into the South Korea aesthetic devices market, especially among clinics chasing premium procedure pricing.

High Capital & Maintenance Costs of Advanced Devices

Thermage FLX and Ultherapy systems list above USD 150,000, while annual service contracts add 12-15% of purchase value. Hospital-backed groups absorb these costs, but many stand-alone clinics in Daejeon or Gwangju resort to refurbished units that extend ROI horizons. Only 18% of 2025 installations used third-party leasing, far below Japan’s 42%, reflecting conservative lending by Korean banks. Extended payback discourages clinics from early adoption, stretching the upgrade cycle in the South Korea aesthetic devices market.

Other drivers and restraints analyzed in the detailed report include:

• Aging Population Drives Anti-Aging Demand
• Growing Male Aesthetics Market Segment
• Stringent MFDS Approval Timelines & Compliance Costs

Segment Analysis

The non-energy devices segment accounts for 54.52% share within the South Korea aesthetic devices market, as Class II approval times have shortened by four months. Dermal fillers anchored by Hugel and Medytox now last 8-10 months, driving repeat traffic among 35-50-year-olds. Biodegradable threads gain favor with male patients seeking jawline refinement without surgery. Home-use microdermabrasion tools from Dr. Jart+ extend the care continuum, although margins remain lower than clinic-grade hardware.

The energy-based devices segment is anticipated to register the fastest CAGR of 8.56%, thanks to high-priced lasers and RF units that underpin clinic differentiation. Picosecond platforms own 38% of energy sales, and Jeisys’s Ultraformer series raises the bar with depth-customized HIFU. Average selling prices for IPL units dropped 12% in 2025 as Alma and Lumenis launched entry models targeting medical spas. Combination systems that fuse RF with ultrasound gained six MFDS clearances in 2025, signaling a hybrid future for the South Korea aesthetic devices market.

Skin rejuvenation & tightening segment led with 32.51% share, yet body contouring & cellulite reduction is expanding at 9.12% CAGR through demand for cryolipolysis and electromagnetic muscle stimulation. Classys’s Clatuu Alpha shipped 28% more units in 2025, reflecting consumer appetite for non-surgical fat reduction. Diode lasers are overtaking alexandrite in hair removal, improving efficacy for darker skin. Scar and pigmentation care benefits from fractional lasers like Lutronic’s eCO2 Plus, which cuts overheating events by 34% through thermal imaging. Tattoo & vascular lesion removal grows 5.80% annually as picosecond systems break down resistant ink shades, widening clinical indications inside the South Korean aesthetic devices market.

Complete Report Scope:

• By Device Type
  • Energy-based Devices
    • Laser-based
    • Radiofrequency
    • IPL & Light-based
    • Ultrasound / HIFU
  • Non-energy Devices
    • Dermal Fillers & Injectables
    • Implants
    • Microdermabrasion & Dermarollers
• By Application
  • Skin Rejuvenation & Tightening
  • Body Contouring & Cellulite Reduction
  • Hair Removal
  • Scar, Acne & Pigmentation Treatment
  • Tattoo & Vascular Lesion Removal
  • Others
• By End User
  • Hospitals
  • Aesthetic & Dermatology Clinics
  • Medical Spas
  • Home-Use / Consumer
• By Gender
  • Female
  • Male
• By Age Group
  • 18-34 Years
  • 35-50 Years
  • Above 50 Years

List of Companies Covered in this Report:

• Abbvie
• Bausch Health
• Candela Corporation
• CLASSYS Inc.
• Cutera
• Cynosure Lutronic
• Daewoong Pharmaceutical Co., Ltd.
• Eunsung Global
• Fotona
• Galderma
• Hironic Co., Ltd
• HUGEL
• Jeisys Medical Inc.
• LASEROPTEK
• Lumenis Be Ltd
• Medytox
• Merz Pharma
• Sciton
• Sinclair
• Sisram Medical
• Tiger Aesthetics Medical, LLC (Sientra, Inc.)
• wontech Co., Ltd

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support